Beginning Cash: The amount of cash reported by the company on its previous statement.
Fate Therapeutics, Inc. (FATE) had Beginning Cash of $46.28M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$6.65M |
|
$-136.31M |
|
-- |
|
$6.65M |
|
$154.35M |
|
$-147.70M |
|
$11.39M |
|
$-136.31M |
|
$-136.31M |
|
$-136.31M |
|
$-136.31M |
|
$-136.31M |
|
$-136.31M |
|
$-147.70M |
|
$-138.41M |
|
118.79M |
|
118.79M |
|
$-1.15 |
|
$-1.15 |
|
| Balance Sheet Financials | |
$208.70M |
|
$56.92M |
|
$110.23M |
|
$318.94M |
|
$36.07M |
|
-- |
|
$75.68M |
|
$111.75M |
|
$207.18M |
|
$207.18M |
|
$207.18M |
|
115.36M |
|
| Cash Flow Statement Financials | |
$-106.08M |
|
$111.17M |
|
$5.49M |
|
|
Beginning Cash |
$46.28M |
$56.85M |
|
$10.57M |
|
$24.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2222.45% |
|
-2222.45% |
|
-2082.59% |
|
-2051.08% |
|
-2051.08% |
|
$-111.67M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
7.26 |
|
50.31 |
|
-65.80% |
|
-65.79% |
|
-42.74% |
|
-65.79% |
|
$1.80 |
|
$-0.94 |
|
$-0.89 |
|